Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1075 of 3499 entries
View as:

Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03327883 Org: User:
Start: 10/26/17 End: 10/16/18 Due: 10/16/19

Survey of Prostate Cancer in Accra, Ghana

Phase: N/A Priority: Normal
NCT ID: NCT00339534 Org: User:
Start: 06/26/02 End: 05/15/20 Due: 05/15/21

RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01193868 Org: User:
Start: 09/30/10 End: 04/30/14 Due: 04/30/15

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002723 Org: User:
Start: 01/31/96 End: 03/31/08 Due: 03/31/09

Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00095693 Org: User:
Start: 10/31/04 End: 12/31/11 Due: 12/31/12

Sequential Vaccinations in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00060528 Org: User:
Start: 05/22/03 End: 06/08/09 Due: 06/08/10

Cancer Markers Associated With Occupational Exposure to Trichloroethylene

Phase: N/A Priority: Normal
NCT ID: NCT00481611 Org: User:
Start: 06/15/06 End: 10/30/20 Due: 10/30/21

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00331682 Org: User:
Start: 03/31/06 End: 05/31/08 Due: 05/31/09

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01175980 Org: User:
Start: 08/06/10 End: 08/01/18 Due: 08/01/19

Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study

Phase: N/A Priority: Normal
NCT ID: NCT00342433 Org: User:
Start: 05/05/99 End: 05/15/20 Due: 05/15/21

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01533194 Org: User:
Start: 04/30/12 End: 02/28/15 Due: 02/28/16

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00079404 Org: User:
Start: 03/31/04 End: - Due: -

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

Phase: N/A Priority: Normal
NCT ID: NCT01143571 Org: User:
Start: 11/20/09 End: - Due: -

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Phase: N/A Priority: Normal
NCT ID: NCT00001701 Org: User:
Start: 07/29/98 End: - Due: -

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00006016 Org: User:
Start: 05/31/00 End: 04/30/05 Due: 04/30/06

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00828139 Org: User:
Start: 05/31/09 End: 09/30/12 Due: 09/30/13

AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00397878 Org: User:
Start: 11/30/06 End: 11/30/11 Due: 11/30/12

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00126581 Org: User:
Start: 08/15/05 End: 11/28/17 Due: 11/28/18

Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

Phase: N/A Priority: Normal
NCT ID: NCT00489372 Org: User:
Start: 07/31/07 End: 07/31/09 Due: 07/31/10

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Phase: N/A Priority: Normal
NCT ID: NCT00026676 Org: User:
Start: 05/31/00 End: 04/30/03 Due: 04/30/04

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00335998 Org: User:
Start: 03/31/06 End: - Due: -

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001449 Org: User:
Start: 09/30/95 End: 04/30/00 Due: 04/30/01

Biomarkers for Breast Cancer Risk in African American Women

Phase: N/A Priority: Normal
NCT ID: NCT01736306 Org: User:
Start: 07/23/12 End: 03/27/20 Due: 03/27/21

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03027388 Org: User:
Start: 01/09/19 End: 08/31/22 Due: 08/31/23

Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00438464 Org: User:
Start: 02/28/07 End: 04/30/12 Due: 04/30/13